HHS Secretary Alex Azar. Photo: Chris Kleponis / Getty Images

The White House is out with a long list of proposals to help bring down the cost of prescription drugs, through a combination of direct federal intervention and steps to promote greater competition. At least some of those ideas will be part of the administration's annual budget proposal, according to Bloomberg.

Between the lines: Lowering drug prices is popular, and it's an issue President Trump has spoken about a lot. And the outline the White House released today is much more detailed than many of its other policy proposals. Still, the White House budget is mostly a messaging document — most real policy action has to come from Congress.

The details: Here's what will be in the budget proposal Monday, per Bloomberg:

  • Ensuring Medicare enrollees benefit directly from discounts negotiated by drugmakers and middlemen.
  • Capping out-of -pocket prescription drug costs.
  • Potentially making generic drugs free for low-income Medicare enrollees.
  • Moving drugs administered in a doctor's office from Medicare Part B to Part D, which would set up negotiations with insurers over the price of these drugs.
  • Reduce Part B payments from 6% above the average sales price to 3%.
  • Redistribute the savings from a program that gives drug discounts to hospitals that treat a high number of low-income people.
  • Begin a Medicaid pilot program that would allow state programs to exclude some drugs from their list of covered treatments, a way to get bigger discounts.

Key quote: The administration plans to address drug prices “with the same zeal and vigor that you saw on taxes," Mick Mulvaney, director of the Office of Management and Budget, told Bloomberg. “This is a top, top priority for the president."

Go deeper

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Politics: Trump calls Fauci a "disaster" on campaign call.
  2. Health: Coronavirus hospitalizations are on the rise — 8 states set single-day coronavirus case records last week.
  3. States: California to independently review FDA-approved coronavirus vaccines
  4. Wisconsin judge reimposes capacity limit on indoor venues.
  5. Media: Trump attacks CNN as "dumb b*stards" for continuing to cover pandemic.
  6. Business: Consumer confidence surveys show Americans are getting nervousHow China's economy bounced back from coronavirus.
  7. Sports: We've entered the era of limited fan attendance.
  8. Education: Why education technology can’t save remote learning.
Dion Rabouin, author of Markets
2 hours ago - Economy & Business

The 2020 holiday season may just kill Main Street

Illustration: Eniola Odetunde/Axios

Online retail and e-commerce have been chipping away at brick-and-mortar businesses over the years but the combination of the coronavirus pandemic and the 2020 holiday season may prove to be a knockout blow.

State of play: Anxious consumers say financial concerns and health worries will push them to spend less money this year and to do more of their limited spending online.

California to independently review FDA-approved coronavirus vaccines

California Gov. Gavin Newsom. Photo: Justin Sullivan/Getty Images

California will "independently review" all coronavirus vaccines approved by the Food and Drug Administration before allowing their distribution, Gov. Gavin Newsom (D) announced at a news conference Monday.

Why it matters: The move that comes days after NAID director Anthony Fauci said he had "strong confidence" in FDA-approved vaccines could cast further public doubt that the federal government could release a vaccine based on political motives, rather than safety and efficacy.